948894-76-6 Usage
Chemical structure
Contains a tetrahydro-4(1H)-pyridinone ring with a benzyloxyethyl group attached to one of the carbon atoms.
Functional groups
Tetrahydro-4(1H)-pyridinone ring, benzyloxyethyl group.
Molecular weight
Approximately 221.28 g/mol.
Appearance
Typically a solid or crystalline substance.
Solubility
Soluble in organic solvents such as ethanol, methanol, and dichloromethane.
Stability
Stable under normal temperature and pressure conditions, but sensitive to heat, light, and moisture.
Reactivity
Can undergo various chemical reactions, such as substitution, addition, and elimination reactions, due to the presence of the tetrahydro-4(1H)-pyridinone ring and benzyloxyethyl group.
Synthesis
Commonly synthesized through the reaction of a tetrahydro-4(1H)-pyridinone derivative with a benzyloxyethyl halide or tosylate.
Applications
Used as a precursor or intermediate in the synthesis of various pharmaceuticals and organic compounds.
Potential use
Known for its potential use as a building block in the development of new therapeutic agents.
Importance
The presence of the benzyloxyethyl group makes it a versatile starting material for the synthesis of other complex molecules, making it an important component in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 948894-76-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,8,8,9 and 4 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 948894-76:
(8*9)+(7*4)+(6*8)+(5*8)+(4*9)+(3*4)+(2*7)+(1*6)=256
256 % 10 = 6
So 948894-76-6 is a valid CAS Registry Number.
948894-76-6Relevant academic research and scientific papers
PHENETHANOLAMINE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS
-
Page/Page column 108-109, (2008/06/13)
The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta2 adrenoreceptor agonists.
